Hanna-Riikka Lehto1, Arto Pietilä1, Teemu J Niiranen1,2, Jyri Lommi3, Veikko Salomaa1. 1. THL - Finnish Institute for Health and Welfare, Helsinki, Finland. 2. Department of Medicine, Turku University Hospital and University of Turku, Turku, Finland. 3. Division of Cardiology, Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland.
Abstract
Aims: To compare diabetic patients with coronary heart disease (CHD) needing revascularization to corresponding non-diabetic patients in terms of revascularization methods, comorbidities and urgency of procedure. We also examined the impact of patient characteristics and comorbidities on the revascularization method. Methods: We identified all diabetic (n = 33,018) and non-diabetic (n = 106,224) patients with first-ever, percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) from electronic health records in Finland between 2000 and 2015. Results: Overall, PCI was the most common revascularization method. PCI outnumbered CABG in women and men both in diabetic and non-diabetic patients. However, diabetic patients were more likely to undergo CABG than PCI (OR 1.30; 95% CI 1.27-1.34, adjusted for age, gender, region of residence and procedure year). Moreover, 26.9% of diabetic patients' urgent procedures were CABG compared to 21.6% in non-diabetic patients (p<.001). Among diabetic patients, prior myocardial infarction was associated with increased odds of CABG, whereas female gender, atrial fibrillation, congestive heart failure, hypertension and later procedure year were associated with lower odds of CABG.Conclusions: CABG has been performed more frequently in diabetic than in non-diabetic CHD patients. Nevertheless, PCI was the dominant revascularization method over CABG both in diabetic and non-diabetic patients. KEY MESSAGESPCI was the dominant revascularization method in both diabetic and non-diabetic patients. Diabetic patients were more likely to undergo CABG than PCI when compared to non-diabetic patients (OR: 1.30; CI 1.27-1.34).Diabetic patients underwent urgent CABG procedures more often than non-diabetic patients and had more comorbidities compared to non-diabetic patients.
Aims: To compare diabeticpatients with coronary heart disease (CHD) needing revascularization to corresponding non-diabeticpatients in terms of revascularization methods, comorbidities and urgency of procedure. We also examined the impact of patient characteristics and comorbidities on the revascularization method. Methods: We identified all diabetic (n = 33,018) and non-diabetic (n = 106,224) patients with first-ever, percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) from electronic health records in Finland between 2000 and 2015. Results: Overall, PCI was the most common revascularization method. PCI outnumbered CABG in women and men both in diabetic and non-diabeticpatients. However, diabeticpatients were more likely to undergo CABG than PCI (OR 1.30; 95% CI 1.27-1.34, adjusted for age, gender, region of residence and procedure year). Moreover, 26.9% of diabeticpatients' urgent procedures were CABG compared to 21.6% in non-diabeticpatients (p<.001). Among diabeticpatients, prior myocardial infarction was associated with increased odds of CABG, whereas female gender, atrial fibrillation, congestive heart failure, hypertension and later procedure year were associated with lower odds of CABG.Conclusions: CABG has been performed more frequently in diabetic than in non-diabetic CHDpatients. Nevertheless, PCI was the dominant revascularization method over CABG both in diabetic and non-diabeticpatients. KEY MESSAGESPCI was the dominant revascularization method in both diabetic and non-diabeticpatients. Diabeticpatients were more likely to undergo CABG than PCI when compared to non-diabeticpatients (OR: 1.30; CI 1.27-1.34).Diabeticpatients underwent urgent CABG procedures more often than non-diabeticpatients and had more comorbidities compared to non-diabeticpatients.
Authors: Timo Mäkikallio; Niels R Holm; Mitchell Lindsay; Mark S Spence; Andrejs Erglis; Ian B A Menown; Thor Trovik; Markku Eskola; Hannu Romppanen; Thomas Kellerth; Jan Ravkilde; Lisette O Jensen; Gintaras Kalinauskas; Rikard B A Linder; Markku Pentikainen; Anders Hervold; Adrian Banning; Azfar Zaman; Jamen Cotton; Erlend Eriksen; Sulev Margus; Henrik T Sørensen; Per H Nielsen; Matti Niemelä; Kari Kervinen; Jens F Lassen; Michael Maeng; Keith Oldroyd; Geoff Berg; Simon J Walsh; Colm G Hanratty; Indulis Kumsars; Peteris Stradins; Terje K Steigen; Ole Fröbert; Alastair N J Graham; Petter C Endresen; Matthias Corbascio; Olli Kajander; Uday Trivedi; Juha Hartikainen; Vesa Anttila; David Hildick-Smith; Leif Thuesen; Evald H Christiansen Journal: Lancet Date: 2016-10-31 Impact factor: 79.321
Authors: Francesco Cosentino; Peter J Grant; Victor Aboyans; Clifford J Bailey; Antonio Ceriello; Victoria Delgado; Massimo Federici; Gerasimos Filippatos; Diederick E Grobbee; Tina Birgitte Hansen; Heikki V Huikuri; Isabelle Johansson; Peter Jüni; Maddalena Lettino; Nikolaus Marx; Linda G Mellbin; Carl J Östgren; Bianca Rocca; Marco Roffi; Naveed Sattar; Petar M Seferović; Miguel Sousa-Uva; Paul Valensi; David C Wheeler Journal: Eur Heart J Date: 2020-01-07 Impact factor: 29.983
Authors: Arie Pieter Kappetein; Stuart J Head; Marie-Claude Morice; Adrian P Banning; Patrick W Serruys; Friedrich-Wilhelm Mohr; Keith D Dawkins; Michael J Mack Journal: Eur J Cardiothorac Surg Date: 2013-02-14 Impact factor: 4.191
Authors: Tuomas O Kiviniemi; Arto Pietilä; Jarmo M Gunn; Jenni M Aittokallio; Markku S Mähönen; Veikko V Salomaa; Teemu J Niiranen Journal: EuroIntervention Date: 2016-10-20 Impact factor: 6.534
Authors: Edward L Hannan; Chuntao Wu; Gary Walford; Alfred T Culliford; Jeffrey P Gold; Craig R Smith; Robert S D Higgins; Russell E Carlson; Robert H Jones Journal: N Engl J Med Date: 2008-01-24 Impact factor: 91.245
Authors: Michael E Farkouh; Michael Domanski; Lynn A Sleeper; Flora S Siami; George Dangas; Michael Mack; May Yang; David J Cohen; Yves Rosenberg; Scott D Solomon; Akshay S Desai; Bernard J Gersh; Elizabeth A Magnuson; Alexandra Lansky; Robin Boineau; Jesse Weinberger; Krishnan Ramanathan; J Eduardo Sousa; Jamie Rankin; Balram Bhargava; John Buse; Whady Hueb; Craig R Smith; Victoria Muratov; Sameer Bansilal; Spencer King; Michel Bertrand; Valentin Fuster Journal: N Engl J Med Date: 2012-11-04 Impact factor: 91.245
Authors: Subodh Verma; Michael E Farkouh; Bobby Yanagawa; David H Fitchett; Muhammad R Ahsan; Marc Ruel; Sachin Sud; Milan Gupta; Shantanu Singh; Nandini Gupta; Asim N Cheema; Lawrence A Leiter; Paul W M Fedak; Hwee Teoh; David A Latter; Valentin Fuster; Jan O Friedrich Journal: Lancet Diabetes Endocrinol Date: 2013-09-13 Impact factor: 32.069